• Mon, September 16, 2024
Silvan Tuerkcan Reiterated (ACRV) at Buy and Held Target at $17 on, Sep 16th, 2024
Silvan Tuerkcan of JMP Securities, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $17 on, Sep 16th, 2024.
Silvan, nor any peers, have made any analyst calls on ACRV in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
